Coats has announced board and committee changes ahead of its Interim Dividend going ex next week, as it works to bring Leverage down after the OrthoLite acquisition.

Coats Group (LSE:COA), the FTSE 250 supplier of industrial threads, footwear components and related materials, announced board and committee changes on 28 September and disclosed a change in a major shareholding on 2 October. Shareholders are also approaching the ex-dividend date for the interim dividend, set for 15 October, following half-year results published in late July.

Board and committee changes

Non-executive director Srinivas Phatak will step down from the board on 31 December 2026. Wu Gang, also a non-executive director, will join the audit and risk committee from 1 January 2027. Group chief executive David Paja became chair of the sustainability committee with immediate effect from 28 September. The changes follow a period of boardroom renewal earlier in the year, including the appointment of a new chair announced in May.

Half-year results recap

In the six months to 30 June 2026, Revenue rose 19% to $837m, largely reflecting the Acquisition of OrthoLite, the footwear insole specialist, which completed in late October 2025. Organic growth at constant exchange rates was 1%. Adjusted EBIT increased 19% to $166m, with the Margin flat at 19.8%, although on an organic basis adjusted EBIT was 2% lower. Adjusted Basic Earnings Per Share fell to 4.4 cents from 4.7 cents.

By segment, Apparel generated revenue of $486m with 1% organic growth and a margin of 18.9%. Footwear revenue rose to $351m from $223m, mainly because of OrthoLite, with flat organic growth and a margin of 21.1%. The former Performance Materials division has been redistributed between the two segments.

The interim dividend was increased by 5% to 1.05 cents per share. It goes ex-dividend on 15 October, with a Record Date of 16 October and payment on 12 November.

Leverage and outlook

Free Cash Flow in the half was $30m, down from $38m. Net Debt excluding leases rose to $842m at the end of June, from $815m at the end of 2025, equivalent to leverage of 2.3 times. Coats said it expects leverage to fall to 2.0 times or below by the year end.

The company kept its full-year expectations unchanged, forecasting good year-on-year earnings growth and solid free cash flow, in line with its target of around $1bn of cumulative free cash flow over five years. Its guidance assumes modest market declines in the second half, offset by around $15m of additional cost benefits, including synergies from OrthoLite, which is expected to return to growth in the second half.

Mr Paja said the company was pleased with its first-half outperformance relative to the market and confident in its outlook for the second half, highlighting the resilience of its margins and cash flow in weak conditions.

Coats' customers are global apparel and footwear brands and their manufacturers, so its trading is linked to consumer Demand for clothing and shoes as well as to inventory cycles and shifts in global trade and tariffs. For FTSE 250 investors, the second half will test whether cost savings and OrthoLite's recovery can offset softer end markets, with the full-year results due early next year.

The upcoming dividend payment is relatively modest in size, but the 5% increase signals the board's confidence in cash generation even as the group works through the integration of OrthoLite. Management has consistently emphasised cost discipline and margin protection as priorities while demand in its end markets remains subdued, and has reiterated its commitment to reducing leverage over the coming months.